查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825967

2025年流感診斷全球市場報告

Influenza Diagnostic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，流感診斷市場規模穩定成長，從2024年的27.3億美元增加至2025年的28.7億美元，複合年成長率為4.9%。歷史時期的成長歸因於電子商務的成長、勞動力短缺、自動化和生產力的提高、供應鏈最佳化、人事費用的上升以及政府對自動化和機器人技術的支持。

預計未來幾年流感診斷市場規模將強勁成長，2029年將達到39億美元，複合年成長率為8.0%。預測期內的成長可歸因於客製化和可擴展性、環境和永續性目標、提高營運效率的需求以及滿足現代供應鏈動態需求的需求。預測期內的主要趨勢包括先進技術的整合、機器人揀選和包裝、自主移動機器人、即時數據和分析、人工智慧主導的決策、協作機器人以及機器人技術的進步。

流感診斷，通常稱為流感，包括各種檢測流感病毒的測試。這些診斷方法包括病毒培養、血清學檢測、快速抗原檢測、逆轉錄聚合酵素鏈鎖反應(RT-PCR)、螢光檢測和快速分子檢測。流感主要由三種流感病毒引起：甲型、乙型和丙型，其症狀通常包括發燒、喉嚨痛、咳嗽、身體疼痛、疲倦和頭痛。流感診斷市場的收益來自進行流感病毒檢測的營業單位。

傳統的流感診斷檢測包括快速輸注檢測 (RIDT)、病毒培養、DFA、血清學檢測和其他檢測。快速輸注檢測 (RIDT) 是免疫檢測，可識別呼吸道檢體中是否存在甲型和乙型流感病毒核蛋白抗原，並提供定性結果（陽性或陰性）。分子診斷檢測包括多種方法，例如逆轉錄聚合酵素鏈鎖反應(RT-PCR)、恒溫核酸增幅試驗 (INAAT)、環介導等溫擴增試驗、轉錄介導等溫擴增試驗和其他等恒溫核酸增幅試驗。這些檢測方法被醫院、臨床實驗室、診斷參考實驗室、學術/研究機構和其他最終用戶採用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響，尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供流感診斷市場統計數據，例如全球流感診斷行業市場規模、區域佔有率、競爭對手的流感診斷市場佔有率、詳細的流感診斷市場細分、市場趨勢和商業機會，以及您在流感診斷行業取得成功所需的數據。本流感診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切全面觀點。

未來五年8.0%的預測成長率，較我們先前對該市場的預測略有下降0.5%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會增加韓國和德國供應的快速分子流感檢測和多重聚合酵素鏈鎖反應(PCR)系統的成本，從而減緩疫情應對速度並增加檢測成本，對美國公共衛生構成重大挑戰。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響也將更加廣泛。

快速診斷檢測預計將推動流感診斷市場的成長。這些檢測是旨在快速確認或排除病症和疾病的醫療工具，滿足了醫療保健領域對準確及時結果日益成長的需求。快速流感診斷檢測 (RIDT) 因其能夠在 10-15 分鐘內檢測出流感病毒抗原並具有中等靈敏度（50-70%）而備受推崇。例如，澳洲健康與福利研究所 (Australian Institute of Health and Welfare) 在 2024 年 7 月報告稱，影像診斷服務的數量從 2021-22 年的 2840 萬增加到 2022-23 年的 2970 萬。因此，快速診斷檢測的廣泛應用正在推動流感診斷市場的發展。

增加流感診斷研究的資金是推動市場成長的關鍵因素。要了解流感對公共衛生的影響，需要對病毒及其對個人和人群的影響進行全面的研究。加速對公共健康有重大影響的科學進步至關重要。公共和私人衛生組織、研究人員、醫療保健專業人員和生物製藥公司正在增加對研究基金和津貼的投資，以降低疫情流感的風險。例如，2024年10月，澳洲政府透過衛生和老年護理部撥款9,500萬美元用於禽流感應對措施，以保護農業、野生動物和經濟。因此，增加研究資金正在推動流感診斷市場的發展。

流感診斷市場的參與企業正在積極創新和開發突破性產品，例如 Lucira COVID-19 和流感家用檢測試劑盒，該產品可實現快速、同步的定性檢測。這款一次性家用檢測套組可讓使用者在約 30 分鐘內從自行採集的鼻拭子樣本中獲得結果。此類創新的一個例子是輝瑞 Lucira COVID-19 和流感家用檢測試劑盒，該試劑盒於 2023 年 2 月獲得美國製藥公司輝瑞的核准。此檢測試劑盒可同時檢測甲型流感和乙型流感（俗稱流感）以及導致 COVID-19 的 SARS-CoV-2 病毒。

快速流感診斷檢測 (RIDT) 在流感診斷中的應用正日益廣泛。 RIDT 是一種免疫檢測，可識別呼吸道檢體中是否存在甲型和乙型流感病毒核蛋白抗原，並提供定性結果（陽性或陰性）。這些檢測可在約 15 分鐘的臨床相關時限內提供結果，尤其適用於診斷出流感樣症狀的患者，尤其是在症狀出現後四天內。 RIDT 因其易於使用和快速診斷能力而日益普及。

2024年2月，印度醫療保健公司Thyrocare Technologies Limited收購了Think Health Diagnostic Private Limited，使其成為私人公司。此次收購擴展了Thyrocare的服務組合，擴大了客戶推廣，並增強了其在診斷領域的市場佔有率。除了血液診斷外，此次合併還引入了家庭心電圖檢測，將Thyrocare定位為提供體檢前和年度健康檢查的綜合服務提供者。 Think Health Diagnostic 私人公司是一家總部位於印度的居家醫療保健服務公司，專門提供遠端醫療、實驗室檢測和藥房服務。

流感診斷市場的主要企業包括 F. Hoffmann-La Roche Ltd.、Quidel Corporation、Thermo Fisher Scientific Inc.、Abbott Laboratories、Hologic Inc.、Becton Dickinson and Company、DiaSorin SpA、Luminex Corporation、Meridian Bioscience Inc.、GenMark Diagnostics Inc.、SASiagnos LLC. Healthineers AG、Coris Bioconcept Sprl、Mast Group、Elitech Technology lnc.、Analytik Jena AG、altona Diagnostics GmbH、Tecan Trading AG、Genome Diagnostics Pvt Ltd.、Germaine Laboratories Inc.、Response Biomedical Corporation、TAUNS Laborator Inc. Inc.、TotalWellness Ltd.、Health Advocate Inc.、Optum Global Solutions Private Ltd. 等。

2024年，北美是流感診斷市場最大的地區。西歐是流感診斷市場的第二大地區。流感診斷市場報告涵蓋以下地區：亞太地區、西歐、東歐、北美、南美以及中東和非洲。

流感診斷市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙、加拿大

流感診斷市場包括檢測套組、試劑和其他產品的收益。市場規模包括服務供應商銷售或包含在其服務產品中的相關商品的價值。僅包括企業之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球流感診斷：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球流感診斷市場：成長率分析
  • 全球流感診斷市場表現：規模與成長，2019-2024
  • 全球流感診斷市場預測：2024-2029年、2034年規模與成長
  • 全球流感診斷：總目標市場（TAM）

第6章 市場細分

  • 全球流感診斷市場（按常規診斷測試、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 快速流感診斷測試（RIDT）
  • 病毒培養
  • 直接螢光抗體（DFA）檢測
  • 血清學檢測
  • 其他
  • 全球流感診斷市場（按分子診斷測試）：2019-2024 年、2024-2029 年和 2034 年的表現和預測
  • 逆轉錄聚合酵素鏈鎖反應（RT-PCR）
  • 恒溫核酸增幅檢測（INAAT）
  • 恒溫環型核酸擴增試驗
  • 轉錄介導的等溫擴增試驗
  • 其他等恒溫核酸增幅試驗
  • 其他分子診斷測試
  • 全球流感診斷市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和臨床實驗室
  • 診斷參考實驗室
  • 學術研究機構
  • 其他
  • 全球流感診斷市場：快速流感診斷測試（RIDT）細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 免疫檢測測定測試
  • 橫向流動化驗
  • 酵素免疫分析法（EIA）
  • 全球流感診斷市場：病毒培養細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 細胞培養
  • 雞蛋培養
  • 全球流感診斷市場：直接螢光抗體 (DFA) 測試細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 直接螢光抗體染色
  • 全球流感診斷市場：血清學檢測細分，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 血凝抑制（HI）試驗
  • 酵素免疫分析法（ELISA）
  • 西方印漬術試驗
  • 全球流感診斷市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應（PCR）
  • 螢光試驗

第7章 區域和國家分析

  • 全球流感診斷市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球流感診斷市場（依國家/地區分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 流感診斷市場：競爭格局
  • 流感診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Hologic Inc.

第31章：其他領先和創新企業

  • Becton Dickinson and Company
  • DiaSorin SpA
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • GenMark Diagnostics Inc.
  • SA Scientific Ltd.
  • Sekisui Diagnostics LLC
  • bioMerieux Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Coris Bioconcept Sprl
  • Mast Group
  • Elitech Technology Inc.
  • Analytik Jena AG
  • altona Diagnostics GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年流感診斷市場：提供新機會的國家
  • 2029年流感診斷市場：細分市場將帶來新機會
  • 2029年流感診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32605u

The diagnosis of influenza, commonly known as the flu, involves employing various tests to detect the presence of the influenza virus. These diagnostic methods include viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza is caused by three primary types of the influenza virus such as type A, type B, and type C. Its symptoms typically include fever, sore throat, cough, body ache, fatigue, and headache. The market for influenza diagnostics encompasses the revenues generated by entities involved in conducting tests for the detection of the influenza virus.

The conventional diagnostic tests for influenza comprise rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays, and other tests. Rapid influenza diagnostic tests (RIDTs) are immunoassays capable of identifying the presence of influenza A and B viral nucleoprotein antigens in respiratory samples, offering a qualitative outcome (positive or negative). Molecular diagnostic tests encompass a range of methods such as Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop-mediated isothermal-based amplification assays, transcription-mediated isothermal-based amplification assays, and other isothermal nucleic acid amplification tests. These tests are employed by hospitals, clinical laboratories, diagnostic reference laboratories, academic/research institutes, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The influenza diagnostic market research report is one of a series of new reports from The Business Research Company that provides influenza diagnostic market statistics, including influenza diagnostic industry global market size, regional shares, competitors with a influenza diagnostic market share, detailed influenza diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the influenza diagnostic industry. This influenza diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The influenza diagnostic market size has grown steadily in recent years. It will grow from $2.73 billion in 2024 to $2.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to e-commerce growth, labor shortages, automation and productivity, supply chain optimization, rising costs of labor, government support for automation and robotics.

The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.9 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to customization and scalability, environmental and sustainability goals, need to improve operational efficiency, need to meet the demands of modern supply chain dynamics. Major trends in the forecast period include advanced technology integration, robotic picking and packing, autonomous mobile robots, real-time data and analytics, ai-driven decision making, collaborative robots, advancements in robotic technology.

The forecast of 8.0% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. public health by increasing costs for rapid molecular influenza tests and multiplex Polymerase Chain Reaction(PCR) systems sourced from South Korea and Germany, potentially delaying outbreak responses and raising laboratory testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Rapid diagnostic tests are anticipated to drive the growth of the influenza diagnostic market. These tests are medical tools designed to quickly confirm or rule out a condition or disease, addressing the rising demand for accurate and timely results in healthcare. Rapid influenza diagnostic tests (RIDTs) are particularly valued for their ability to detect influenza viral antigens within 10-15 minutes, offering moderate sensitivity (50-70%). For example, in July 2024, the Australian Institute of Health and Welfare reported that diagnostic imaging services increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Consequently, the growing adoption of rapid diagnostic tests is propelling the influenza diagnostic market.

Increasing funding for research on influenza diagnostics is a key factor driving market growth. Understanding the public health impact of influenza requires comprehensive research into the virus and its effects on individuals and populations. Accelerating scientific advancements with significant public health implications is essential. Public and private health organizations, researchers, healthcare professionals, and biopharmaceutical companies have been increasing investments in research funding or grants to mitigate the risks of pandemic influenza. For example, in October 2024, the Australian Government, through the Department of Health and Aged Care, allocated $95 million to combat avian influenza, aimed at protecting agriculture, wildlife, and the economy. As a result, increasing research funding is propelling the influenza diagnostic market.

Key players in the influenza diagnostic market are actively innovating and developing groundbreaking products like the Lucira COVID-19 & Flu Home Test, allowing rapid simultaneous qualitative detection. This single-use at-home test kit enables users to obtain results from self-collected nasal swab samples in approximately 30 minutes. An example of such innovation is the approval received by Pfizer Inc., a US-based pharmaceutical company, in February 2023 for the Lucira by Pfizer COVID-19 & Flu Home Test. This test is capable of detecting both influenza A and B (commonly known as the flu) and SARS-CoV-2, the virus responsible for COVID-19.

The utilization of rapid influenza diagnostic tests (RIDTs) in influenza diagnostics is increasingly prevalent. RIDTs, which are immunoassays, identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, providing a qualitative result (positive or negative). These tests deliver outcomes within a clinically relevant timeframe of approximately 15 minutes and are particularly effective in diagnosing patients with influenza-like symptoms, especially within the first four days of symptom onset. The growing favor for RIDTs is attributed to their user-friendly nature and swift diagnostic capabilities.

In February 2024, Thyrocare Technologies Limited, an India-based healthcare company, acquired Think Health Diagnostic Private Limited for an undisclosed amount. The acquisition expands Thyrocare's service portfolio, enabling broader customer outreach and strengthening its market share in the diagnostic sector. This integration also introduces at-home ECG testing alongside blood diagnostics, establishing Thyrocare as a comprehensive provider for premedical and annual health checkups. Think Health Diagnostic Private Limited is an India-based home healthcare services company specializing in telehealth, laboratory testing, and pharmacy services.

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMerieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the influenza diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The influenza diagnostic market includes revenue earned by test kit and reagents, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Influenza Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on influenza diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for influenza diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The influenza diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests
  • 2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
  • 3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users
  • Subsegments:
  • 1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)
  • 2) By Viral Culture: Cell Culture; Egg-based Culture
  • 3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining
  • 4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay
  • 5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Quidel Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Hologic Inc.; Becton Dickinson and Company; DiaSorin SpA; Luminex Corporation; Meridian Bioscience Inc.; GenMark Diagnostics Inc.; SA Scientific Ltd.; Sekisui Diagnostics LLC; bioMerieux Inc.; Danaher Corporation; Siemens Healthineers AG; Coris Bioconcept Sprl; Mast Group; Elitech Technology lnc.; Analytik Jena AG; altona Diagnostics GmbH; Tecan Trading AG; Genome Diagnostics Pvt Ltd.; Germaine Laboratories Inc.; Response Biomedical Corporation; TAUNS Laboratories Inc.; TRUPCR Europe Ltd.; Quest Diagnostics Inc.; Labcorp Employer Services Inc.; TotalWellness Ltd.; Health Advocate Inc.; Optum Global Solutions Private Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Influenza Diagnostic Market Characteristics

3. Influenza Diagnostic Market Trends And Strategies

4. Influenza Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Influenza Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Influenza Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Influenza Diagnostic Market Growth Rate Analysis
  • 5.4. Global Influenza Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Influenza Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Influenza Diagnostic Total Addressable Market (TAM)

6. Influenza Diagnostic Market Segmentation

  • 6.1. Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Influenza Diagnostic Tests (RIDT)
  • Viral Culture
  • DFA
  • Serological Assays
  • Other Traditional Diagnostic Tests
  • 6.2. Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  • Isothermal Nucleic Acid Amplification Tests (INAAT)
  • Loop Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Other Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Diagnostic Tests
  • 6.3. Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Other End Users
  • 6.4. Global Influenza Diagnostic Market, Sub-Segmentation Of Rapid Influenza Diagnostic Tests (RIDT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay-based Tests
  • Lateral Flow Assays
  • Enzyme Immunoassays (EIA)
  • 6.5. Global Influenza Diagnostic Market, Sub-Segmentation Of Viral Culture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture
  • Egg-based Culture
  • 6.6. Global Influenza Diagnostic Market, Sub-Segmentation Of Direct Fluorescent Antibody (DFA) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Fluorescent Antibody Staining
  • 6.7. Global Influenza Diagnostic Market, Sub-Segmentation Of Serological Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemagglutination Inhibition (HI) Assay
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blotting Assay
  • 6.8. Global Influenza Diagnostic Market, Sub-Segmentation Of Other Traditional Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Immunofluorescence Assays

7. Influenza Diagnostic Market Regional And Country Analysis

  • 7.1. Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Influenza Diagnostic Market

  • 8.1. Asia-Pacific Influenza Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Influenza Diagnostic Market

  • 9.1. China Influenza Diagnostic Market Overview
  • 9.2. China Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Influenza Diagnostic Market

  • 10.1. India Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Influenza Diagnostic Market

  • 11.1. Japan Influenza Diagnostic Market Overview
  • 11.2. Japan Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Influenza Diagnostic Market

  • 12.1. Australia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Influenza Diagnostic Market

  • 13.1. Indonesia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Influenza Diagnostic Market

  • 14.1. South Korea Influenza Diagnostic Market Overview
  • 14.2. South Korea Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Influenza Diagnostic Market

  • 15.1. Western Europe Influenza Diagnostic Market Overview
  • 15.2. Western Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Influenza Diagnostic Market

  • 16.1. UK Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Influenza Diagnostic Market

  • 17.1. Germany Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Influenza Diagnostic Market

  • 18.1. France Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Influenza Diagnostic Market

  • 19.1. Italy Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Influenza Diagnostic Market

  • 20.1. Spain Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Influenza Diagnostic Market

  • 21.1. Eastern Europe Influenza Diagnostic Market Overview
  • 21.2. Eastern Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Influenza Diagnostic Market

  • 22.1. Russia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Influenza Diagnostic Market

  • 23.1. North America Influenza Diagnostic Market Overview
  • 23.2. North America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Influenza Diagnostic Market

  • 24.1. USA Influenza Diagnostic Market Overview
  • 24.2. USA Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Influenza Diagnostic Market

  • 25.1. Canada Influenza Diagnostic Market Overview
  • 25.2. Canada Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Influenza Diagnostic Market

  • 26.1. South America Influenza Diagnostic Market Overview
  • 26.2. South America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Influenza Diagnostic Market

  • 27.1. Brazil Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Influenza Diagnostic Market

  • 28.1. Middle East Influenza Diagnostic Market Overview
  • 28.2. Middle East Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Influenza Diagnostic Market

  • 29.1. Africa Influenza Diagnostic Market Overview
  • 29.2. Africa Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Influenza Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Influenza Diagnostic Market Competitive Landscape
  • 30.2. Influenza Diagnostic Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Influenza Diagnostic Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. DiaSorin SpA
  • 31.3. Luminex Corporation
  • 31.4. Meridian Bioscience Inc.
  • 31.5. GenMark Diagnostics Inc.
  • 31.6. SA Scientific Ltd.
  • 31.7. Sekisui Diagnostics LLC
  • 31.8. bioMerieux Inc.
  • 31.9. Danaher Corporation
  • 31.10. Siemens Healthineers AG
  • 31.11. Coris Bioconcept Sprl
  • 31.12. Mast Group
  • 31.13. Elitech Technology Inc.
  • 31.14. Analytik Jena AG
  • 31.15. altona Diagnostics GmbH

32. Global Influenza Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Influenza Diagnostic Market

34. Recent Developments In The Influenza Diagnostic Market

35. Influenza Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Influenza Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Influenza Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Influenza Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer